Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial

Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial

Authors of this article:

Nikhil Chauhan¹ ;   Janet Bukovcan¹ ;   Eveline Boucher¹ ;   David Cosgrove² ;   Julien Edeline³ ;   Bonnie Hamilton¹ ;   Laura Kulik⁴ ;   Fayaz Master¹ ;   Riad Salem^{5, 6, 7}